NORA O'SULLIVAN: Open Payments
NPI 1265210132 · MONROE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$763 in 23 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $447 · 2025 $763
Food & beverage: $763
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $198 |
| PFIZER INC. | 6 | $151 |
| Edwards Lifesciences Corporation | 2 | $150 |
| Actelion Pharmaceuticals US, Inc. | 2 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $52 |
| E.R. Squibb & Sons, L.L.C. | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
Products named: WAINUA, VYNDAQEL, UPTRAVI, JARDIANCE, LifeVest, PASCAL, CAMZYOS, Kerendia.
Industry payments across CT — which companies pay providers there.
